Profile
Stephen A.
Ross worked as Senior Vice President-Sales & Marketing at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. in 2007-2008, Chief Commercial Officer & EVP at Ikaria, Inc., Vice President-Specialty Business Units at GSK Plc in 2007, and General Manager at GlaxoSmithKline (Ireland) Ltd.
He completed his undergraduate degree at Brigham Young University and earned an MBA from The Wharton School of the University of Pennsylvania.
Former positions of Stephen A. Ross
| Companies | Position | End |
|---|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Sales & Marketing | 2008-07-31 |
| GSK PLC | Corporate Officer/Principal | 2007-05-31 |
GlaxoSmithKline (Ireland) Ltd.
 GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Corporate Officer/Principal | - |
| IKARIA, INC. | Corporate Officer/Principal | - |
Training of Stephen A. Ross
| Brigham Young University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
GlaxoSmithKline (Ireland) Ltd.
GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Stephen A. Ross
